Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptability assay

Medical Mycology

Volumn 43, Issue 6, 2005, Pages 525-532

  Wetter, Tracy J ^a,c   Hazen, Kevin C ^b   Cutler, Jim E ^c  

^a MONTANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

Antifungal susceptibility; Aspergillus fumigatus; MIC; Rapid susceptibility assay

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; GLUCOSE; ITRACONAZOLE; VORICONAZOLE;

ANALYTIC METHOD; ARTICLE; ASPERGILLUS FUMIGATUS; CONIDIUM; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGUS HYPHAE; FUNGUS ISOLATION; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; STANDARDIZATION; TEMPERATURE MEASUREMENT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; HUMANS; HYPHAE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

ASPERGILLUS FUMIGATUS; FUNGI;

EID: 28244440441     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500050796     Document Type: Article

References (18)

1. Chen J, Wan Z, Li R. Modified colorimetric assay for susceptibility testing of azole antifungal drugs against Candida species. J Clin Micro 2004; 42: 1790-1793.
2. Lass-Florl C, Speth C, Kofier G, et al. Effect of increasing inoculum sizes of Aspergillus hyphae on MIC and MFC of antifungal agents by broth microdilution method. Int J Antimicrob Agents 2003; 21: 229-233.
3. Riesselman MH, Hazen KC, Cutler JE. Determination of antifungal MICs by a rapid susceptibility assay. J Clin Micro 2000; 38: 333-340.
4. Li RK, Elie CM, Clayton GE, Cibalak MA. Comparison of new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination. J Clin Micro 2000; 38: 2334-2338.
5. Wetter TJ, Cutler JE. Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus. J Clin Micro 2003; 41: 4252-4258.
6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard, NCCLS document M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards, 1998.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: Approved standard. NCCLS document M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
8. Espinel-Ingroff A. Germinated and non-germinated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole. Antimicrob Agents Chemother 2001; 45: 605-607.
9. Guarro J, Llop C, Aguilar C, Pujol I. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997; 41: 2760-2762.
10. Lass-Florl C, Speth NM, Ulmer CH, Dierich MP, Wurzner R. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother 2001; 45: 124-128.
11. Lass-Florl C, Nagl CM, Gunsilius E, et al. In vitro studies of amphotericin B and lipid - based amphotericin B formulations against Aspergillus conidia and hyphae. Mycoses 2002; 45: 166-169
12. Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Micro 1999; 37: 858-861.
13. Pujol I, Fernandez-Ballart J, Guarro J. Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp. J Antimicrob Chemother 2001; 47: 715-718.
14. Bezjak V. Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing. J Clin Micrbiol 1985; 21: 509-512.
15. Kwong-Chung KJ, Bennett JE. Aspergillosis. In: Carr C (ed.). Medical Mycology. London: Lea and Febiger, 1992: 201-247.
16. Johnson EM, Oakley KL, Radford SA, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45: 85-93.
17. Denning DW, Radford SA, Oakley KL, Johnson EM, Warnock DW. Correlation between in vitro susceptibility testing to itraconazole and in vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
18. Granade TC, Artis WM. Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum. Antimicrob Agents Chemother 1980; 17: 725-729.